2024-514054-70-00招募中1 期
Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2024年8月12日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 14
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Joachim G.J.V. Aerts
Scientific
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Dendritic cell-based immunotherapy against metastatic melanoma patientsmetastatic melanomaJPRN-UMIN000006849Shizuoka Cancer Center24
尚未招募
不适用
Dendritic cell-based immunotherapy combined with low-dose cyclophosphamide in patients with malignant pleural mesotheliomamesothelioma10035597NL-OMON32554Erasmus MC, Universitair Medisch Centrum Rotterdam10
未知
1 期
Dendritic cell therapy and intratumor dendritic cell injection therapy using Tumor associated antigen or tumor lysate for patients with advanced and recurrent canceradvanced and recurrent cancerJPRN-UMIN000000775Fukushima Medical University25
招募中
不适用
Immunotherapy in mesothelioma patients.mesotheliomamesothelioomasbestkankerborstvlieskankerNL-OMON24867Erasmus Medical CenterDepartment of Pulmonary MedicineRotterdam10
已完成
1 期
Dendritic cell-based tumor-specific immunotherapy against malignant brain tumor - Phase I clinical trialMalignant brain tumor (malignant glioma)JPRN-UMIN000000914Shizuoka Cancer Center12